Cargando…

Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions

Glioblastoma (GBM) is among the most fatal and recurring malignant solid tumors. It arises from the GBM stem cell population. Conventional neurosurgical resection, temozolomide (TMZ)-dependent chemotherapy and radiotherapy have rendered the prognosis of patients unsatisfactory. Radiotherapy and chem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mingming, Wang, Xiaojie, Jin, Xiaoyan, Zhou, Jingjing, Zhang, Yufu, Yang, Yiyuan, Liu, Yusi, Zhang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248152/ https://www.ncbi.nlm.nih.gov/pubmed/37304305 http://dx.doi.org/10.3389/fimmu.2023.1175118

Ejemplares similares

Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions
por: Mao, Lili, et al.
Publicado: (2021)

Current Status and Future Directions of Bacteria-Based Immunotherapy
por: Tang, Quan, et al.
Publicado: (2022)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Current landscape and future directions of bispecific antibodies in cancer immunotherapy
por: Wei, Jing, et al.
Publicado: (2022)

Immunotherapy in Lung Cancer: Current Landscape and Future Directions
por: Mamdani, Hirva, et al.
Publicado: (2022)

Immunotherapy for Glioblastoma: Current Progress and Challenges
por: Yu, Miranda W., et al.
Publicado: (2021)

Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects
por: Liu, Zhuoyan, et al.
Publicado: (2021)

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
Publicado: (2021)

Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future
por: Li, Long, et al.
Publicado: (2020)

Current status and future directions of cancer immunotherapy
por: Zhang, Hongming, et al.
Publicado: (2018)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2022)

Inhibition of STAT3 signaling as critical molecular event in HUC-MSCs suppressed Glioblastoma Cells
por: Wang, Mingming, et al.
Publicado: (2023)

Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond
por: Zhao, Yang, et al.
Publicado: (2023)

Putting Proteomics Into Immunotherapy for Glioblastoma
por: Chen, Liangyu, et al.
Publicado: (2021)

Characterization of Different Subtypes of Immune Cell Infiltration in Glioblastoma to Aid Immunotherapy
por: Feng, Peng, et al.
Publicado: (2022)

Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects
por: Singh, Om Prakash, et al.
Publicado: (2014)

Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions
por: Zhang, Peng, et al.
Publicado: (2022)

Advances in Nanotechnology-Based Immunotherapy for Glioblastoma
por: Tang, Lin, et al.
Publicado: (2022)

Adoptive Cell Therapy in Pediatric and Young Adult Solid Tumors: Current Status and Future Directions
por: Ligon, John A., et al.
Publicado: (2022)

The prognostic biological markers of immunotherapy for non-small cell lung cancer: current landscape and future perspective
por: Liang, Shuai, et al.
Publicado: (2023)

Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
por: Gardam, Bryan, et al.
Publicado: (2023)

Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
por: Sadozai, Hassan, et al.
Publicado: (2017)

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
por: Weenink, Bas, et al.
Publicado: (2020)

Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives
por: Sener, Ugur, et al.
Publicado: (2022)

Immunotherapy for B-Cell Lymphoma: Current Status and Prospective Advances
por: Hollander, Nurit
Publicado: (2012)

Overcoming the immune suppressive nature of glioblastoma by leveraging the surgical intervention - current status and future perspectives
por: Duerinck, Johnny, et al.
Publicado: (2023)

Lymphoma Immunotherapy: Current Status
por: Zappasodi, Roberta, et al.
Publicado: (2015)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Editorial: Pandemic influenza vaccine approaches: Current status and future directions
por: Schotsaert, Michael, et al.
Publicado: (2022)

Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
por: Guo, Zong Sheng, et al.
Publicado: (2017)

Harnessing the B Cell Response in Kidney Transplantation – Current State and Future Directions
por: Anwar, Imran J., et al.
Publicado: (2022)

Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives
por: Yang, Minfeng, et al.
Publicado: (2020)

Current Advances in Immunotherapy for Glioblastoma Multiforme and Future Prospects
por: Chowdhury, Selia, et al.
Publicado: (2021)

Immunotherapy in glioblastoma treatment: Current state and future prospects
por: Rocha Pinheiro, Samuel Luca, et al.
Publicado: (2023)

Immunotherapies Targeting Fish Mucosal Immunity – Current Knowledge and Future Perspectives
por: Koshio, Shunsuke
Publicado: (2016)

Emerging therapies for glioblastoma: current state and future directions
por: Rong, Liang, et al.
Publicado: (2022)

Cellular Immunotherapies for Multiple Myeloma: Current Status, Challenges, and Future Directions
por: Yan, Zhi-Ling, et al.
Publicado: (2022)

Gut microbiota in perioperative neurocognitive disorders: current evidence and future directions
por: Sun, Yan, et al.
Publicado: (2023)

Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma
por: Jian, Yuli, et al.
Publicado: (2021)

CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
por: Burger, Michael C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vsqns4au8bdqsm96rgoa2f2702